Legend Biotech Corporation (LEGN) has been persistently topping new highs in the previous days. On Wednesday Legend Biotech Corporation (LEGN) did it again and price closed at $52.48 slightly changing a 0.48%; new all-time highs are set at $54.85.
Since the price bottomed at $34.86 last August, the stock surged by 50.55%.
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in North America and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM), as well as a comparison of the treatment with standard triplet therapy in relapsed and refractory multiple myeloma.. The stock is part of the Biotechnology industry in the Healthcare sector. The company's Headquarters are in Somerset, United States, and has 900 employees worldwide. Check for further details about the company at its corporate site at http://www.legendbiotech.com.